Agreement signedPublished 2 Nov 2023

Lombardi Sub, LLC /
LimFlow S.A.

Inari Medical subsidiary agrees to buy LimFlow S.A. for $250 million

Buy side: Lombardi Sub, LLC
Buy sideLombardi Sub, LLC
Target: LimFlow S.A.
TargetLimFlow S.A.
Source · 2 Nov 2023
Buy side: Lombardi Sub, LLC
Buy sideLombardi Sub, LLC
Target: LimFlow S.A.
TargetLimFlow S.A.
01 / BuyerLombardi Sub, LLC
02 / TargetLimFlow S.A.
01

What happened

Lombardi Sub, LLC entered into an agreement to purchase all of the equity interests of LimFlow S.A. The initial purchase price is $250,000,000, subject to adjustments, with additional contingent payments of up to $165,000,000.

The transaction is subject to customary closing conditions and was expected to be consummated in the fourth quarter of 2023.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Inari Medical subsidiary agrees to buy LimFlow S.A. for $250 million

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Also stated

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.